TABLE 1.

Baseline characteristics for propensity score–matched patients with or without statin exposure

	Propensity score matched *
	Without statin exposure		With statin exposure
	n	%	n	%	P‐Value
Number of patients	144,301		144,214
Age
45 to 49	11,764	8.15%	6157	4.27%	0.99
50 to 54	10,991	7.62%	7523	5.22%
55 to 59	11,293	7.83%	9844	6.83%
60 to 64	9175	6.36%	10,623	7.37%
65 to 69	35,097	24.32%	37,460	25.98%
70 to 74	27,748	19.23%	33,170	23.00%
75 to 79	18,073	12.52%	21,233	14.72%
80 to 84	11,300	7.83%	11,169	7.74%
85 to 89	2343	1.62%	2717	1.88%
90 and over	6517	4.52%	4318	2.99%
Sex
Female	82,584	57.23%	75,773	52.54%	0.99
Male	61,717	42.77%	68,441	47.46%
Ethnicity
White	105,254	72.94%	115,135	79.84%	0.99
Black	3269	2.27%	5561	3.86%
Asian	258	0.18%	494	0.34%
Hispanic	774	0.54%	1593	1.10%
Other	887	0.61%	1316	0.91%
Unknown	33,859	23.46%	20,115	13.95%
Region
Midwest	33,456	23.18%	28,916	20.05%	0.99
Northeast	3053	2.12%	2663	1.85%
South	91,930	63.71%	98,772	68.49%
West	15,862	10.99%	13,863	9.61%
Comorbidities
T2DM	3817	2.65%	9536	6.61%	0.003
HTN	12,102	8.39%	13,550	9.40%
CVD	2469	1.71%	8901	6.17%
STROKE	2361	1.64%	7274	5.04%
CKD	3500	2.43%	9256	6.42%
COPD	2192	1.52%	4741	3.29%
CCI
0–4	117,275	81.27%	138,329	95.92%	0.99
5–10	24,743	17.15%	5500	3.81%
11+	2283	1.58%	385	0.27%

Abbreviations: CCI, Charlson Comorbidity Index.; CKD, chronic kidney disease; COPD, chronic obstructive pulmonary disease; CVD, cardiovascular disease; HTN, hypertension; T2DM, type‐2 diabetes mellitus.

^*Adjusted for age, sex, region, comorbidities and CCI.